DXR shows concerning cash flow deterioration with substantially reduced dividend payments and declining equity position amid growing liabilities.
The company's financial position weakened notably during fiscal 2012, with operating cash flow remaining deeply negative and management apparently forced to slash dividend payments by three-quarters. The combination of declining stockholders' equity and rising liabilities suggests mounting financial pressure that could constrain future operations and shareholder returns.
DXR's financial profile deteriorated across multiple dimensions in fiscal 2012, with operating cash flow remaining substantially negative at -$6.5M while dividend payments were slashed from $4.2M to $1.1M. The balance sheet reflects growing strain, as stockholders' equity declined 23% to $36.2M while total liabilities increased 12% to $49.5M, suggesting the company is consuming equity to fund operations. Operating expenses showed mixed trends with SG&A rising modestly while R&D spending was reduced, indicating potential cost-cutting pressures.
Dividends cut 75.1% — significant signal of cash flow stress or capital reallocation priorities.
Capex reduced 62.1% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Equity decreased 22.9% — buybacks or losses reducing book value, monitor solvency ratios.
Receivables grew 22.9% — monitor days sales outstanding for collection efficiency.
Inventory reduced 17.1% — lean inventory management or demand outpacing supply.
Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.
Current liabilities rose 12.2% — increased short-term obligations, watch current ratio.
Liabilities increased 12% — monitor debt-to-equity ratio and interest coverage.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
R&D spending cut 11% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →